Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:3132729.
doi: 10.1155/2017/3132729. Epub 2017 Dec 20.

Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors

Mohsen Janghorbani  1 , Ashraf Aminorroaya  1 , Masoud Amini  1
Affiliations

Hypertension in Non-Type 2 Diabetes in Isfahan, Iran: Incidence and Risk Factors

Mohsen Janghorbani et al. Int J Hypertens. 2017.

Abstract

Objective: To estimate the incidence of and risk factors for the development of hypertension (HTN) in people with T1D using routinely collected data.

Method: The mean 16-year incidence of HTN was measured among 1,167 (557 men and 610 women) nonhypertensive patients with T1D from Isfahan Endocrine and Metabolism Research Center outpatient clinics, Iran. HTN was defined as a systolic blood pressure (BP) of 140 mm Hg or higher and/or a diastolic BP 90 mm Hg or higher and/or use of antihypertensive medications. The mean (standard deviation [SD]) age of participants was 20.6 years (10.5 years) with a mean (SD) duration of diabetes of 3.6 years (4.8 years) at registration.

Results: The prevalence of HTN at baseline was 9.7% (95% CI: 8.2, 11.5). Among the 1,167 patients free of HTN at registration who attended the clinic at least twice in the period 1992-2016, the incidence of HTN was 9.6 (8.0 women and 11.3 men) per 1000 person-years based on 18,870 person-years of follow-up. Multivariate analyses showed that male gender, older age, higher triglyceride, and higher systolic BP were significantly and independently associated with the development of HTN in this population.

Conclusion: These findings will help the identification of those patients with T1D at particular risk of HTN and strongly support the case for vigorous control of BP in patients with T1D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram of the study population.
See this image and copyright information in PMC

References

    1. Christlieb A. R., Warram J. H., Królewski A. S., et al. Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes. 1981;30(2):90–96. doi: 10.2337/diab.30.2.S90. - DOI - PubMed
    1. Parving H.-H., Andersen A., Smidt U., Svendsen P. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. The Lancet. 1983;1(8335):1175–1179. doi: 10.1016/s0140-6736(83)92462-5. - DOI - PubMed
    1. Mogensen C. E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. BMJ. 1982;285(6343):685–688. doi: 10.1136/bmj.285.6343.685. - DOI - PMC - PubMed
    1. Teuscher A., Schnell H., Wilson P. W. F. Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care. 1988;11(3):246–251. doi: 10.2337/diacare.11.3.246. - DOI - PubMed
    1. Klein R., Klein B. E. K., Moss S. E., Davis M. D., DeMets D. L. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? JAMA Internal Medicine. 1989;149(11):2427–2432. doi: 10.1001/archinte.149.11.2427. - DOI - PubMed

LinkOut - more resources